News Image

Is NYSE:UVE suited for CANSLIM investing?

By Mill Chart

Last update: Jul 23, 2024

In this article we will dive into UNIVERSAL INSURANCE HOLDINGS (NYSE:UVE) as a possible candidate for growth investing. Investors should always do their own research, but we noticed UNIVERSAL INSURANCE HOLDINGS showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.


Canslim stocks image

Some of the canslim metrics of NYSE:UVE highlighted

  • With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), UNIVERSAL INSURANCE HOLDINGS highlights its ability to generate increasing profitability, showcasing a 35.44% growth.
  • UNIVERSAL INSURANCE HOLDINGS has demonstrated strong q2q revenue growth of 29.31%, suggesting a favorable trend in the company's financials and indicating the potential for continued expansion.
  • UNIVERSAL INSURANCE HOLDINGS has achieved 54.58% growth in EPS over the past 3 years, reflecting a sustained improvement in earnings performance.
  • UNIVERSAL INSURANCE HOLDINGS has achieved an impressive Return on Equity (ROE) of 20.94%, showcasing its ability to generate favorable returns for shareholders.
  • UNIVERSAL INSURANCE HOLDINGS has achieved an impressive Relative Strength (RS) rating of 78.91, showcasing its ability to outperform the broader market. This strong performance positions UNIVERSAL INSURANCE HOLDINGS as an attractive stock for potential price appreciation.
  • UNIVERSAL INSURANCE HOLDINGS maintains a healthy Debt-to-Equity ratio of 0.28. This indicates the company's conservative capital structure and signifies its ability to effectively manage debt obligations while maintaining a strong equity position.
  • With institutional shareholders at 65.19%, UNIVERSAL INSURANCE HOLDINGS demonstrates a healthy ownership distribution. This reflects a mix of institutional and individual investors, creating a market environment that may foster increased trading activity and price discovery.

In-Depth Technical Analysis of NYSE:UVE

Every day, ChartMill assigns a Technical Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various technical indicators and properties.

We assign a technical rating of 7 out of 10 to UVE. UVE has been one of the better performers in the overall market. Some doubts were observed in the medium time frame, but recent action was again very positive.

  • The long and short term trends are both positive. This is looking good!
  • Looking at the yearly performance, UVE did better than 78% of all other stocks. On top of that, UVE also shows a nice and consistent pattern of rising prices.
  • UVE is currently trading in the upper part of its 52 week range. The S&P500 Index however is currently trading near a new high, so UVE is lagging the market slightly.
  • In the last month UVE has a been trading in the 17.72 - 20.09 range, which is quite wide. It is currently trading near the high of this range.
  • UVE is part of the Insurance industry. There are 141 other stocks in this industry, UVE did better than 66% of them.

Check the latest full technical report of UVE for a complete technical analysis.

Zooming in on the fundamentals.

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

UVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. UVE has an average financial health and profitability rating. UVE has a correct valuation and a medium growth rate. UVE also has an excellent dividend rating.

Our latest full fundamental report of UVE contains the most current fundamental analsysis.

Our CANSLIM screen will find you more ideas suited for growth investing.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back